- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-26-0261867

Sryntek Pharmaceutical Private Limited
About Sryntek Pharmaceutical Private Limited
Data last updated:
Sryntek Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 May 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2022PTC211142. Its GSTIN is 27ABICS4752M1ZQ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santoshidevi Yadav and Santosh Jagatpal Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Milkat No.1627 Shop No.4 Manterwadi Haveli Pune Uruli Dewachi, Maharashtra, India – 412308.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.19 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1,769 (net margin 0.1%) and EBITDA of ₹95,077 (EBITDA margin 5.2%).
Sryntek Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0261867).
Company details
Recognitions & Rankings of Sryntek Pharmaceutical
Contact details
Sryntek Pharmaceutical Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressMilkat No.1627 Shop No.4 Manterwadi Haveli Pune Uruli Dewachi, Maharashtra, India – 412308
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sryntek Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sryntek Pharmaceutical Private Limited, buy the company report.
Financials of Sryntek Pharmaceutical Private Limited
FY 2025 filings availableSryntek Pharmaceutical Private Limited reported revenue of ₹18.19 Lakh (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 28% in the latest year. EBITDA rose 21% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹95,077 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1,769 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.2% | ||
| Net Profit Margin | 0.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sryntek Pharmaceutical Private Limited, buy the company report.
Board of directors of Sryntek Pharmaceutical Private Limited
Sryntek Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santoshidevi Yadav | Director | 10 May 2022 | 4 Years 5 Months | Current |
| Santosh Jagatpal Yadav | Director | 10 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Sryntek Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vijay Remedies Limited | ₹18.31 Lakh (FY 2025) | 167.0% | Delhi, India | |||
| Stepan Laboratories Private Limited | ₹18.27 Lakh (FY 2025) | -76.0% | New Delhi, Delhi, India | |||
| Sryntek Pharmaceutical Private Limitedthis company | ₹18.19 Lakh (FY 2025) | ₹1,769 | 0.1% | 28.0% | Pune, Maharashtra, India | |
| Relivaid Healthcare India Private Limited | ₹18.18 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Great Lifesciences Private Limited | ₹18.15 Lakh (FY 2022) | -89.0% | Vastral, Gujarat, India | |||
| Creata Pharmaceuticals (I) Private Limited | ₹18.1 Lakh (FY 2024) | 2.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Sryntek Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sryntek Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sryntek Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sryntek Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABICS4752M1ZQ | Maharashtra | Active | 03 Jun 2022 |
To see the full GST registrations and return filing status of Sryntek Pharmaceutical Private Limited, buy the company report.
Recent activity
Sryntek Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Santosh Jagatpal Yadav was appointed as Director on 10 May 2022.
Frequently asked questions
Sryntek Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 May 2022 (4+ years old) and is registered under CIN U24290PN2022PTC211142.
Sryntek Pharmaceutical has 2 current directors:
- Santoshidevi Yadav - Director
- Santosh Jagatpal Yadav - Director
The latest financial statements of Sryntek Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Sryntek Pharmaceutical is 27ABICS4752M1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sryntek Pharmaceutical is U24290PN2022PTC211142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sryntek Pharmaceutical was incorporated on 10 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Sryntek Pharmaceutical by revenue are Vijay Remedies Limited, Stepan Laboratories Private Limited, Relivaid Healthcare India Private Limited, Great Lifesciences Private Limited, Creata Pharmaceuticals (I) Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Santosh Jagatpal Yadav was appointed as Director on 10 May 2022. Santoshidevi Yadav was appointed as Director on 10 May 2022.
Yes, Sryntek Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0261867).
The registered office of Sryntek Pharmaceutical is at Milkat No.1627 Shop No.4 Manterwadi Haveli Pune Uruli Dewachi, Maharashtra, India – 412308.
Sryntek Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.

